Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586173 | SCV000697624 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530915 | SCV001646434 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358647 | SCV002655165 | likely benign | Cardiovascular phenotype | 2022-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004802283 | SCV005426581 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-09-16 | criteria provided, single submitter | clinical testing |